Japan Intellectual Property Rights: IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF

Japan, Aug. 6 -- METABOMED LTD has got intellectual property rights for 'IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF.' Other related details are as follows:

Application Number: JP,2025-128256

Category (FI): A61P3/04,A61P25/00,A61P37/02,A61K31/501,A61K31/5377,C07D413/10,C07D401/10,A61K45/00,A61P43/00,121,A61P35/00,A61P25/32,A61P31/12,A61P3/06,A61P1/16,A61P3/00,A61P29/00,C07D405/10,A61K31/675,C07D403/10,C07D401/04,A61K31/497,A61K31/506,A61K31/4164,C07D233/90,A61K31/4439,A61P35/04

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 31, 2025

Publication Date: Oct. 28, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated...